Ligand · TOO

TOO · (4S)-4-[2-(2-{4-[(2E)-4-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}-4-oxobut-2-en-1-yl]piperazin-1-yl}ethoxy)acetamido]-1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-L-prolinamide bound form

TOO, (4S)-4-[2-(2-{4-[(2E)-4-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}-4-oxobut-2-en-1-yl]piperazin-1-yl}ethoxy)acetamido]-1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4…

Component: TOO
Formula: C61 H81 N13 O7
Class: ligand
Structures: 1
PDB entries: 1

Binding sites

TOO in 1 structure; the first of them:

8DSO · Structure of cIAP1, BTK and BCCov · TOO B701 · binds LEU408, GLY409, THR410, GLY411, GLN412, VAL416, ALA428, LYS430 and 32 more

Residues it binds most

LEU 1, GLY 1, ASP 1, GLU 1, MET 1, VAL 1, ARG 1, ASN 1, CYS 1, LYS 1 (residue and the binding sites it lines).

Found with

ZN · Zinc ion

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.